Brazil researchers report more modest 50.4% efficacy for China's CoronaVac

RIO DE JANEIRO (Reuters) - A coronavirus vaccine developed by China's Sinovac showed 'general efficacy' of 50.4% in a late-stage trial in Brazil, the company's local partners said on Tuesday, revealing a more modest figure after pressure for more transparency. On Thursday, the Brazilian researchers had celebrated results showing 78% efficacy against mild COVID-19 cases, a rate they have since described as 'clinical efficacy.' Ricardo Palacios, medical director for clinical research at the Butantan biomedical center in Sao Paulo, said the new figure included infections classified as 'very mild' because they did not require clinical assistance. Piecemeal disclosure from global studies of the vaccine, called CoronaVac, have added to concerns that immunizations developed by Chinese producers are not subject to the same public scrutiny as U.S.

Reuters January 13, 2021 00:13:52 IST
Brazil researchers report more modest 50.4% efficacy for China's CoronaVac

Brazil researchers report more modest 504 efficacy for Chinas CoronaVac

RIO DE JANEIRO (Reuters) - A coronavirus vaccine developed by China's Sinovac showed "general efficacy" of 50.4% in a late-stage trial in Brazil, the company's local partners said on Tuesday, revealing a more modest figure after pressure for more transparency.

On Thursday, the Brazilian researchers had celebrated results showing 78% efficacy against mild COVID-19 cases, a rate they have since described as "clinical efficacy."

Ricardo Palacios, medical director for clinical research at the Butantan biomedical center in Sao Paulo, said the new figure included infections classified as "very mild" because they did not require clinical assistance.

Piecemeal disclosure from global studies of the vaccine, called CoronaVac, have added to concerns that immunizations developed by Chinese producers are not subject to the same public scrutiny as U.S. and European alternatives.

Researchers at Butantan delayed the announcement of their results three times, blaming a confidentiality clause in a contract with Sinovac.

Turkish researchers said last month that CoronaVac was 91.25% effective based on an interim analysis. Indonesia gave the vaccine emergency use approval on Monday based on interim data showing it is 65% effective.

Butantan officials said the design of the Brazilian study, focusing on frontline health workers during a severe outbreak in Brazil and including elderly volunteers, made it impossible to compare the results directly with other trials or vaccines.

(Reporting by Gabriel Stargardter and Pedro Fonseca; Editing by Brad Haynes)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

also read

France, Germany to agree to NATO role against Islamic State - sources
| Reuters
World

France, Germany to agree to NATO role against Islamic State - sources | Reuters

By Robin Emmott and John Irish | BRUSSELS/PARIS BRUSSELS/PARIS France and Germany will agree to a U.S. plan for NATO to take a bigger role in the fight against Islamic militants at a meeting with President Donald Trump on Thursday, but insist the move is purely symbolic, four senior European diplomats said.The decision to allow the North Atlantic Treaty Organization to join the coalition against Islamic State in Syria and Iraq follows weeks of pressure on the two allies, who are wary of NATO confronting Russia in Syria and of alienating Arab countries who see NATO as pushing a pro-Western agenda."NATO as an institution will join the coalition," said one senior diplomat involved in the discussions. "The question is whether this just a symbolic gesture to the United States

China's Xi says navy should become world class
| Reuters
World

China's Xi says navy should become world class | Reuters

BEIJING Chinese President Xi Jinping on Wednesday called for greater efforts to make the country's navy a world class one, strong in operations on, below and above the surface, as it steps up its ability to project power far from its shores.China's navy has taken an increasingly prominent role in recent months, with a rising star admiral taking command, its first aircraft carrier sailing around self-ruled Taiwan and a new aircraft carrier launched last month.With President Donald Trump promising a US shipbuilding spree and unnerving Beijing with his unpredictable approach on hot button issues including Taiwan and the South and East China Seas, China is pushing to narrow the gap with the U.S. Navy.Inspecting navy headquarters, Xi said the navy should "aim for the top ranks in the world", the Defence Ministry said in a statement about his visit."Building a strong and modern navy is an important mark of a top ranking global military," the ministry paraphrased Xi as saying.